APA
Ayers E. C., Li S., Medeiros L. J., Bond D. A., Maddocks K. J., Torka P., Mier Hicks A., Curry M., Wagner-Johnston N. D., Karmali R., Behdad A., Fakhri B., Kahl B. S., Churnetski M. C., Cohen J. B., Reddy N. M., Modi D., Ramchandren R., Howlett C., Leslie L. A., Cytryn S., Diefenbach C. S., Faramand R., Chavez J. C., Olszewski A. J., Liu Y., Barta S. K., Mukhija D., Hill B. T., Ma H., Amengual J. E., Nathan S., Assouline S. E., Orellana-Noia V. M., Portell C. A., Chandar A., David K. A., Giri A., Hess B. T. & Landsburg D. J. (20200701). Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. : Cancer.
Chicago
Ayers Emily C, Li Shaoying, Medeiros L Jeffrey, Bond David A, Maddocks Kami J, Torka Pallawi, Mier Hicks Angel, Curry Madeira, Wagner-Johnston Nina D, Karmali Reem, Behdad Amir, Fakhri Bita, Kahl Brad S, Churnetski Michael C, Cohen Jonathon B, Reddy Nishitha M, Modi Dipenkumar, Ramchandren Radhakrishnan, Howlett Christina, Leslie Lori A, Cytryn Samuel, Diefenbach Catherine S, Faramand Rawan, Chavez Julio C, Olszewski Adam J, Liu Yang, Barta Stefan K, Mukhija Dhruvika, Hill Brian T, Ma Helen, Amengual Jennifer E, Nathan Sunita, Assouline Sarit E, Orellana-Noia Victor M, Portell Craig A, Chandar Ashwin, David Kevin A, Giri Anshu, Hess Brian T and Landsburg Daniel J. 20200701. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. : Cancer.
Harvard
Ayers E. C., Li S., Medeiros L. J., Bond D. A., Maddocks K. J., Torka P., Mier Hicks A., Curry M., Wagner-Johnston N. D., Karmali R., Behdad A., Fakhri B., Kahl B. S., Churnetski M. C., Cohen J. B., Reddy N. M., Modi D., Ramchandren R., Howlett C., Leslie L. A., Cytryn S., Diefenbach C. S., Faramand R., Chavez J. C., Olszewski A. J., Liu Y., Barta S. K., Mukhija D., Hill B. T., Ma H., Amengual J. E., Nathan S., Assouline S. E., Orellana-Noia V. M., Portell C. A., Chandar A., David K. A., Giri A., Hess B. T. and Landsburg D. J. (20200701). Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. : Cancer.
MLA
Ayers Emily C, Li Shaoying, Medeiros L Jeffrey, Bond David A, Maddocks Kami J, Torka Pallawi, Mier Hicks Angel, Curry Madeira, Wagner-Johnston Nina D, Karmali Reem, Behdad Amir, Fakhri Bita, Kahl Brad S, Churnetski Michael C, Cohen Jonathon B, Reddy Nishitha M, Modi Dipenkumar, Ramchandren Radhakrishnan, Howlett Christina, Leslie Lori A, Cytryn Samuel, Diefenbach Catherine S, Faramand Rawan, Chavez Julio C, Olszewski Adam J, Liu Yang, Barta Stefan K, Mukhija Dhruvika, Hill Brian T, Ma Helen, Amengual Jennifer E, Nathan Sunita, Assouline Sarit E, Orellana-Noia Victor M, Portell Craig A, Chandar Ashwin, David Kevin A, Giri Anshu, Hess Brian T and Landsburg Daniel J. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. : Cancer. 20200701.